Please use this identifier to cite or link to this item:
https://doi.org/10.3390/IDR13010021
Title: | Deranged coagulation profile secondary to cefazolin use: Case report | Authors: | Ngiam, JN Liong, TS Tham, SM Pramotedham, T AlAgha, R Yong, J Tambyah, P.A. HON WAI, LIONEL LUM |
Keywords: | cefazolin coagulopathy elevated international normalised ratio |
Issue Date: | 1-Mar-2021 | Publisher: | MDPI AG | Citation: | Ngiam, JN, Liong, TS, Tham, SM, Pramotedham, T, AlAgha, R, Yong, J, Tambyah, P.A., HON WAI, LIONEL LUM (2021-03-01). Deranged coagulation profile secondary to cefazolin use: Case report. Infectious Disease Reports 13 (1) : 187-190. ScholarBank@NUS Repository. https://doi.org/10.3390/IDR13010021 | Abstract: | Cefazolin is a widely used first-generation cephalosporin. While generally well tolerated, several case reports have described severe coagulopathy induced by intravenous (IV) cefazolin. This was seen particularly in patients with impaired renal function, where antibiotic choice is limited and may require specific dose adjustments. Altered renal handling of antibiotics and their metabolites may potentiate toxicity and side effects. We report a case of a 72-year-old Chinese man who had been treated for methicillin-sensitive staphylococcus aureus (MSSA, coagulase-positive) infective endocarditis with cefazolin and, consequently, developed significantly elevated international normalised ratio (INR) while on therapy. This resolved within 48 h after cessation of cefazolin and administration of oral vitamin K. Malnourished patients with pre-existing or acute kidney injury may be at an increased risk of cefazolin-related coagulopathy. | Source Title: | Infectious Disease Reports | URI: | https://scholarbank.nus.edu.sg/handle/10635/206221 | ISSN: | 2036-7430 2036-7449 |
DOI: | 10.3390/IDR13010021 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Deranged Coagulation Profile Secondary to Cefazolin Use Case Report.pdf | 447.33 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.